Press Releases
Alliance4Growth, an Advisory and Transactional Consulting Firm, Announces Its Participation to BIO 2012
The recently formed strategic, transactional and operational advisory firm, Alliance4Growth (A4G), is pleased to announce its participation to the BIO US conference, a premier venue in the Life Sciences and Biotechnology arenas, in support to its endeavors with...
Press Releases
Adocia announces a strengthened intellectual property on its lead project for its chronic wounds treatment
Adocia , a biotechnology company specialized in the development of best-in-class medicines with already-approved therapeutic proteins, announces that the USPTO and the EPO have issued a patent covering BioChaperone PDGF formulations for chronic wound treatment, including diabetic foot ulcer, to...
Press Releases
Syapse Launches Application to Make Omics Data Actionable in Clinical R&D
Syapse announced today the commercial launch of Discovery, its cloud-based application for making omics data actionable in clinical research and development. Discovery combines a powerful platform for aggregating and structuring biomedical data with intuitive...
Press Releases
Trophos appoints Christine Placet as chief executive officer
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the appointment of Christine Placet as chief executive officer, effective immediately. ...
Press Releases
Cytheris appoints Damian Marron as chief executive officer
Cytheris SA, a privately held clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today the appointment of Damian Marron as chief executive officer. Damian was previously CEO at Trophos SA. The first task...
Press Releases
Sanofi Submits Application for Regulatory Approval for Lyxumia for the Treatment of Type 2 Diabetes in Japan
Sanofi announced today that the marketing authorization application for Lyxumia, an investigational once-daily GLP-1 receptor agonist has been submitted for review to the Ministry of Health, Labour and Welfare in Japan. The application is...
Press Releases
FDA Correct to Delay Ruling on Gilead’s Controversial HIV ‘Prevention’ Pill
AIDS Healthcare Foundation (AHF), the nation’s largest HIV/AIDS nonprofit medical provider, welcomed the news today that the Food and Drug Administration (FDA) is delaying a ruling on and application by Gilead Sciences for the possible approval of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read